Kathryn Hoffmann, Astrid Hainzl, Michael Stingl, Katharina Kurz, Beate Biesenbach, Christoph Bammer, Uta Behrends, Wolfgang Broxtermann, Florian Buchmayer, Anna Maria Cavini, Gregory Sacha Fretz, Markus Gole, Bettina Grande, Tilman Grande, Lotte Habermann-Horstmeier, Verena Hackl, Jürg Hamacher, Joachim Hermisson, Martina King, Sonja Kohl, Sandra Leiss, Daniela Litzlbauer, Herbert Renz-Polster, Wolfgang Ries, Jonas Sagelsdorff, Carmen Scheibenbogen, Bernhard Schieffer, Lena Schön, Claudia Schreiner, Kevin Thonhofer, Maja Strasser, Thomas Weber, Eva Untersmayr
{"title":"[关于肌痛性脑脊髓炎/慢性疲劳综合征诊断和治疗的 D-A-CH(德国、奥地利和瑞士)跨学科合作共识声明]。","authors":"Kathryn Hoffmann, Astrid Hainzl, Michael Stingl, Katharina Kurz, Beate Biesenbach, Christoph Bammer, Uta Behrends, Wolfgang Broxtermann, Florian Buchmayer, Anna Maria Cavini, Gregory Sacha Fretz, Markus Gole, Bettina Grande, Tilman Grande, Lotte Habermann-Horstmeier, Verena Hackl, Jürg Hamacher, Joachim Hermisson, Martina King, Sonja Kohl, Sandra Leiss, Daniela Litzlbauer, Herbert Renz-Polster, Wolfgang Ries, Jonas Sagelsdorff, Carmen Scheibenbogen, Bernhard Schieffer, Lena Schön, Claudia Schreiner, Kevin Thonhofer, Maja Strasser, Thomas Weber, Eva Untersmayr","doi":"10.1007/s00508-024-02372-y","DOIUrl":null,"url":null,"abstract":"<p><p>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, chronic multisystemic disease which, depending on its severity, can lead to considerable physical and cognitive impairment, loss of ability to work and the need for nursing care including artificial nutrition and, in very severe cases, even death.The aim of this D-A-CH (Germany, Austria, Switzerland) consensus statement is 1) to summarize the current state of knowledge on ME/CFS, 2) to highlight the Canadian Consensus Criteria (CCC) as clinical criteria for diagnostics with a focus on the leading symptom post-exertional malaise (PEM) and 3) to provide an overview of current options and possible future developments, particularly with regard to diagnostics and therapy. The D-A-CH consensus statement is intended to support physicians, therapists and valuer in diagnosing patients with suspected ME/CFS by means of adequate anamnesis and clinical-physical examinations as well as the recommended clinical CCC, using the questionnaires and other examination methods presented. The overview of the two pillars of therapy for ME/CFS, pacing and symptom-relieving therapy options, is intended not only to provide orientation for physicians and therapists, but also to support decision-makers from healthcare policy and insurance companies in determining which therapy options should already be reimbursable by them at this point in time for the indication ME/CFS.</p>","PeriodicalId":23861,"journal":{"name":"Wiener Klinische Wochenschrift","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093804/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].\",\"authors\":\"Kathryn Hoffmann, Astrid Hainzl, Michael Stingl, Katharina Kurz, Beate Biesenbach, Christoph Bammer, Uta Behrends, Wolfgang Broxtermann, Florian Buchmayer, Anna Maria Cavini, Gregory Sacha Fretz, Markus Gole, Bettina Grande, Tilman Grande, Lotte Habermann-Horstmeier, Verena Hackl, Jürg Hamacher, Joachim Hermisson, Martina King, Sonja Kohl, Sandra Leiss, Daniela Litzlbauer, Herbert Renz-Polster, Wolfgang Ries, Jonas Sagelsdorff, Carmen Scheibenbogen, Bernhard Schieffer, Lena Schön, Claudia Schreiner, Kevin Thonhofer, Maja Strasser, Thomas Weber, Eva Untersmayr\",\"doi\":\"10.1007/s00508-024-02372-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, chronic multisystemic disease which, depending on its severity, can lead to considerable physical and cognitive impairment, loss of ability to work and the need for nursing care including artificial nutrition and, in very severe cases, even death.The aim of this D-A-CH (Germany, Austria, Switzerland) consensus statement is 1) to summarize the current state of knowledge on ME/CFS, 2) to highlight the Canadian Consensus Criteria (CCC) as clinical criteria for diagnostics with a focus on the leading symptom post-exertional malaise (PEM) and 3) to provide an overview of current options and possible future developments, particularly with regard to diagnostics and therapy. The D-A-CH consensus statement is intended to support physicians, therapists and valuer in diagnosing patients with suspected ME/CFS by means of adequate anamnesis and clinical-physical examinations as well as the recommended clinical CCC, using the questionnaires and other examination methods presented. The overview of the two pillars of therapy for ME/CFS, pacing and symptom-relieving therapy options, is intended not only to provide orientation for physicians and therapists, but also to support decision-makers from healthcare policy and insurance companies in determining which therapy options should already be reimbursable by them at this point in time for the indication ME/CFS.</p>\",\"PeriodicalId\":23861,\"journal\":{\"name\":\"Wiener Klinische Wochenschrift\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093804/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Wiener Klinische Wochenschrift\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00508-024-02372-y\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener Klinische Wochenschrift","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00508-024-02372-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, chronic multisystemic disease which, depending on its severity, can lead to considerable physical and cognitive impairment, loss of ability to work and the need for nursing care including artificial nutrition and, in very severe cases, even death.The aim of this D-A-CH (Germany, Austria, Switzerland) consensus statement is 1) to summarize the current state of knowledge on ME/CFS, 2) to highlight the Canadian Consensus Criteria (CCC) as clinical criteria for diagnostics with a focus on the leading symptom post-exertional malaise (PEM) and 3) to provide an overview of current options and possible future developments, particularly with regard to diagnostics and therapy. The D-A-CH consensus statement is intended to support physicians, therapists and valuer in diagnosing patients with suspected ME/CFS by means of adequate anamnesis and clinical-physical examinations as well as the recommended clinical CCC, using the questionnaires and other examination methods presented. The overview of the two pillars of therapy for ME/CFS, pacing and symptom-relieving therapy options, is intended not only to provide orientation for physicians and therapists, but also to support decision-makers from healthcare policy and insurance companies in determining which therapy options should already be reimbursable by them at this point in time for the indication ME/CFS.
期刊介绍:
The Wiener klinische Wochenschrift - The Central European Journal of Medicine - is an international scientific medical journal covering the entire spectrum of clinical medicine and related areas such as ethics in medicine, public health and the history of medicine. In addition to original articles, the Journal features editorials and leading articles on newly emerging topics, review articles, case reports and a broad range of special articles. Experimental material will be considered for publication if it is directly relevant to clinical medicine. The number of international contributions has been steadily increasing. Consequently, the international reputation of the journal has grown in the past several years. Founded in 1888, the Wiener klinische Wochenschrift - The Central European Journal of Medicine - is certainly one of the most prestigious medical journals in the world and takes pride in having been the first publisher of landmarks in medicine.